Interstitial lung disease associated with docetaxel in patients with advanced non-small cell lung cancer

Anticancer Research

Volumn 32, Issue 3, 2012, Pages 1103-1106

  Tamiya, Akihiro ^a   Naito, Tateaki ^a   Miura, Satoru ^a   Morii, Sakae ^a   Tsuya, Asuka ^a   Nakamura, Yukiko ^a   Kaira, Kyoichi ^a   Haruyasu, Murakami ^a   Toshiaki, Takahashi ^a   Nobuyuki, Yamamoto ^a   Endo, Masahiro ^a  

^a SHIZUOKA CANCER CENTER   (Japan)

Author keywords

Docetaxel; Interstitial change; Interstitial lung disease; Non small cell lung cancer; Pulmonary emphysema

Indexed keywords

DOCETAXEL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; FEMALE; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THORAX RADIOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG DISEASES, INTERSTITIAL; LUNG NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TAXOIDS;

EID: 84858763481     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Lee JJ and Harris LN: Antimicrotubule agents. In: DeVita VT, Hellman S and Rosenberg SA (eds.). Cancer Principles and Practice of Oncology, 8th edn. Philadelphia: Lippincott Williams and Wilkins, pp. 447-456, 2008.
2. Schiff PB, Fant J and Horwitz SB: Promotion of microtubule assembly in vitro by taxol. Nature 277: 665, 1979.
3. Karakan O, Eyüboglu FO, Akçay S and Ozyilkan O: Acute interstitial pneumopathy associated with docetaxel hypersensitivity. Onkologie 27: 563-565, 2004. (Pubitemid 39664151)
4. Karasawa K, Katsui K, Seki K et al: Radiotherapy with concurrent docetaxel for advanced and recurrent breast cancer. Breast Cancer 10: 268-274, 2003.
5. Behrens RJ, Gulley JL and Dahut WL: Pulmonary toxicity during prostate cancer treatment with docetaxel and thalidomide. Am J Ther 10: 228-232, 2003.
6. Dunsford ML, Mead GM, Bateman AC et al: Severe pulmonary toxicity in patients treated with a combination of docetaxel and gemcitabine for metastatic transitional cell carcinoma. Ann Oncol 10: 943-947, 1999. (Pubitemid 29424574)
7. Grande C, Villanueva MJ, Huidobro G, Casal J et al: Docetaxel-induced interstitial pneumonitis following non-small cell lung cancer treatment. Clin Transi Oncol 9: 578-581, 2007.
8. Chen YM, Shif JF, Pemg RP et al: A randomized trial of different docetaxel schedules in non-small cell lung cancer patients who failed previous platinum-based chemotherapy. Chest 129: 1031-1038, 2006.
9. Maruyama R, Nishiwaki Y, Tamura T et al: Phase III study, V15-32, of gefitinib versus docetaxel in previously treated Japanese patients with non-small-cell lung cancer. J Clin Oncol 26: 4244-4252, 2008.
10. Kim ES, Hirsh V, Mok T et al: Gefitinib versus docetaxel in previously treated non-small cell lung cancer (INTEREST): A randomized phase III trial. Lancet 372: 1809-1818, 2008.
11. Kudoh S, Kato H, Nishiwaki Y et al: Interstitial lung disease in Japanese patients with lung cancer. Am J Respir Crit Care Med 177: 1348-1357, 2008.